Skip to main content

Advertisement

Log in

The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs

  • Clinical Applications of Biomaterials
  • Original Research
  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

The effect of human parathyroid hormone 1–34 (PTH) and simvastatin (SIM) alone could promote bone healing in osteoporotic implant fixation, but there are no reports about the combined use of PTH and SIM for promotion of bone healing around implant in osteoporotic settings. This study aims to investigate effects of PTH + SIM on implant stabilization in osteopenic rats. Fourteen weeks after chronically fed a low protein diet, osteopenic rats randomly received implants. Subsequently, the animals were randomly divided into four groups: Control, SIM, PTH and PTH + SIM. Then all rats from groups PTH, SIM and PTH + SIM received PTH (40 μg/kg, three times a week), SIM (25 mg/kg, daily), or both for 12 weeks. The results of our study indicated that all treatments promoted bone healing around implant compared to Control, but PTH + SIM treatment showed significantly stronger effects than PTH or SIM alone in histological, micro-CT, and biomechanical tests. The results indicated additive effects of PTH and SIM on implant fixation in osteoporotic rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91(1):128–33. doi:10.2106/JBJS.H.00155.

    Article  Google Scholar 

  2. Duarte PM, Cesar Neto JB, Goncalves PF, Sallum EA, Nociti F Jr. Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent. 2003;12(4):340–6.

    Article  Google Scholar 

  3. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997;66(2):460S–3S.

    Google Scholar 

  4. Rizzoli R. Nutrition: its role in bone health. Best Pract Res Clin Endocrinol Metab. 2008;22(5):813–29. doi:10.1016/j.beem.2008.08.005.

    Article  Google Scholar 

  5. Bruyere O, Brandi ML, Burlet N, Harvey N, Lyritis G, Minne H, Boonen S, Reginster JY, Rizzoli R, Akesson K. Post-fracture management of patients with hip fracture: a perspective. Curr Med Res Opin. 2008;24(10):2841–51. doi:10.1185/03007990802381430.

    Article  Google Scholar 

  6. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr. 2000;54(Suppl 3):S40–7.

    Article  Google Scholar 

  7. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R. Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res. 2000;15(4):683–90. doi:10.1359/jbmr.2000.15.4.683.

    Article  Google Scholar 

  8. Dayer R, Rizzoli R, Kaelin A, Ammann P. Low protein intake is associated with impaired titanium implant osseointegration. J Bone Miner Res. 2006;21(2):258–64. doi:10.1359/JBMR.051009.

    Article  Google Scholar 

  9. Marin LA, Salido JA, Lopez A, Silva A. Preoperative nutritional evaluation as a prognostic tool for wound healing. Acta Orthop Scand. 2002;73(1):2–5. doi:10.1080/000164702317281323.

    Article  Google Scholar 

  10. Rai J, Gill SS, Kumar BR. The influence of preoperative nutritional status in wound healing after replacement arthroplasty. Orthopedics. 2002;25(4):417–21.

    Google Scholar 

  11. Hatano H, Maruo A, Bolander ME, Sarkar G. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci. 2003;8(6):842–8. doi:10.1007/s00776-003-0724-9.

    Article  Google Scholar 

  12. Emmanuele L, Ortmann J, Doerflinger T, Traupe T, Barton M. Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth. Biochemical Biophys Res Commun. 2003;302(1):67–72.

    Article  Google Scholar 

  13. Song C, Guo Z, Ma Q, Chen Z, Liu Z, Jia H, Dang G. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochemical Biophys Res Commun. 2003;308(3):458–62.

    Article  Google Scholar 

  14. Wong RW, Rabie AB. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg. 2005;43(1):46–50. doi:10.1016/j.bjoms.2004.08.014.

    Article  Google Scholar 

  15. Alam S, Ueki K, Nakagawa K, Marukawa K, Hashiba Y, Yamamoto E, Sakulsak N, Iseki S. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):22–9. doi:10.1016/j.tripleo.2008.06.025.

    Article  Google Scholar 

  16. Rizzo M, Rini GB. Statins, fracture risk, and bone remodeling: what is true? Am J Med Sci. 2006;332(2):55–60.

    Article  Google Scholar 

  17. Gabet Y, Müller R, Levy J, Dimarchi R, Chorev M, Bab I, Kohavi D. Parathyroid hormone 1–34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. Bone. 2006;39(2):276–82.

    Article  Google Scholar 

  18. Shirota T, Tashiro M, Ohno K, Yamaguchi A. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. J Oral Maxillofac Surg. 2003;61(4):471–80.

    Article  Google Scholar 

  19. Tao ZS, Zhou WS, Qiang Z, Tu KK, Huang ZL, Xu HM, Sun T, Lv YX, Cui W, Yang L. Intermittent administration of human parathyroid hormone (1–34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur. J Biomater Appl. 2015;. doi:10.1177/0885328215610898.

    Google Scholar 

  20. Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L. The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats. Injury. 2015;46(11):2164–9. doi:10.1016/j.injury.2015.08.034.

    Article  Google Scholar 

  21. Ito T, Takemasa M, Makino K, Otsuka M. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice. J Pharm Pharmacol. 2013;65(4):494–502. doi:10.1111/jphp.12008.

    Article  Google Scholar 

  22. Ito T, Saito M, Uchino T, Senna M, Iafisco M, Prat M, Rimondini L, Otsuka M. Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat. J Mater Sci Mater Med. 2012;23(5):1291–7. doi:10.1007/s10856-012-4597-3.

    Article  Google Scholar 

  23. Dayer R, Brennan TC, Rizzoli R, Ammann P. PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet. Osteoporosis Int. 2010;21(6):957–67. doi:10.1007/s00198-009-1031-x.

    Article  Google Scholar 

  24. Xu XC, Chen H, Zhang X, Zhai ZJ, Liu XQ, Qin A, Lu EY. Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy. J Transl Med. 2014;12(1):284. doi:10.1186/s12967-014-0284-0.

    Article  Google Scholar 

  25. He F, Yang G, Wang X, Zhao S. Effect of electrochemically deposited nanohydroxyapatite on bone bonding of sandblasted/dual acid-etched titanium implant. Int J Oral Maxillofac Implants. 2008;24(5):790–9.

    Google Scholar 

  26. Virdi AS, Liu M, Sena K, Maletich J, McNulty M, Ke HZ, Sumner DR. Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. J Bone Joint Surg Am. 2012;94(18):1670–80. doi:10.2106/JBJS.K.00344.

    Article  Google Scholar 

  27. Li YF, Li XD, Bao CY, Chen QM, Zhang H, Hu J. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1–34) and zoledronic acid adsorbed onto the implant surface. Osteoporosis Int. 2013;24(3):1063–71. doi:10.1007/s00198-012-2258-5.

    Article  Google Scholar 

  28. Gabet Y, Kohavi D, Kohler T, Baras M, Müller R, Bab I. Trabecular bone gradient in rat long bone metaphyses: mathematical modeling and application to morphometric measurements and correction of implant positioning. J Bone Miner Res. 2008;23(1):48–57.

    Article  Google Scholar 

  29. Li Y, Li Q, Zhu S, Luo E, Li J, Feng G, Liao Y, Hu J. The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats. Biomaterials. 2010;31(34):9006–14.

    Article  Google Scholar 

  30. Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L. Treatment study of distal femur for parathyroid hormone (1–34) and beta-tricalcium phosphate on bone formation in critical-sized defects in osteopenic rats. J Cranio-maxillo-fac Surg. 2015;. doi:10.1016/j.jcms.2015.09.004.

    Google Scholar 

  31. Bourrin S, Toromanoff A, Ammann P, Bonjour JP, Rizzoli R. Dietary protein deficiency induces osteoporosis in aged male rats. J Bone Miner Res. 2000;15(8):1555–63. doi:10.1359/jbmr.2000.15.8.1555.

    Article  Google Scholar 

  32. Rizzoli R, Ammann P, Chevalley T, Bonjour JP. Protein intake and bone disorders in the elderly. Joint Bone Spine. 2001;68(5):383–92.

    Article  Google Scholar 

  33. Tao ZS, Tu KK, Huang ZL, Zhou Q, Sun T, Xu HM, Zhou YL, Lv YX, Cui W, Yang L. Combined treatment with parathyroid hormone (1–34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model. Med Biol Eng Comput. 2015;. doi:10.1007/s11517-015-1402-8.

    Google Scholar 

  34. Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L. Effect exerted by Teriparatide upon Repair Function of beta-tricalcium phosphate to ovariectomised rat’s femoral metaphysis defect caused by osteoporosis. Injury. 2015;46(11):2134–41. doi:10.1016/j.injury.2015.07.042.

    Article  Google Scholar 

  35. Tao ZS, Zhou Q, Tu KK, Huang ZL, Xu H, Sun T, Lv YX, Cui W. Treatment study of distal femur for parathyroid hormone (1–34) and beta-tricalcium phosphate on bone formation in critical size defects in rats. J Biomater Appl. 2015;. doi:10.1177/0885328215592854.

    Google Scholar 

  36. Dayer R, Badoud I, Rizzoli R, Ammann P. Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate. J Bone Miner Res. 2007;22(10):1526–33. doi:10.1359/jbmr.070610.

    Article  Google Scholar 

  37. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007;357(9):905–16. doi:10.1056/NEJMra067395.

    Article  Google Scholar 

  38. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev. 2005;26(5):688–703. doi:10.1210/er.2004-0006.

    Article  Google Scholar 

  39. Jin J, Zhang X, Lu Z, Li Y, Lopes-Virella MF, Yu H, Haycraft CJ, Li Q, Kirkwood KL, Huang Y. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease. J Periodontal Res. 2014;49(4):518–26. doi:10.1111/jre.12132.

    Article  Google Scholar 

  40. Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res. 2004;19(5):737–44. doi:10.1359/JBMR.040209.

    Article  Google Scholar 

  41. Thabit A, Alhifany A, Alsheikh R, Namnqani S, Al-Mohammadi A, Elmorsy S, Qari M, Ardawi M. Effect of simvastatin and atorvastatin on serum vitamin d and bone mineral density in hypercholesterolemic patients: a cross-sectional study. J Osteoporos. 2014;2014:468397. doi:10.1155/2014/468397.

    Article  Google Scholar 

  42. Chen PY, Sun JS, Tsuang YH, Chen MH, Weng PW, Lin FH. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr Res. 2010;30(3):191–9. doi:10.1016/j.nutres.2010.03.004.

    Article  Google Scholar 

  43. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun. 2001;280(3):874–7.

    Article  Google Scholar 

  44. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem. 2004;92(3):458–71. doi:10.1002/jcb.20074.

    Article  Google Scholar 

  45. Maciel-Oliveira N, Bradaschia-Correa V, Arana-Chavez VE. Early alveolar bone regeneration in rats after topical administration of simvastatin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(2):170–9. doi:10.1016/j.tripleo.2010.08.027.

    Article  Google Scholar 

  46. Naito Y, Terukina T, Galli S, Kozai Y, Vandeweghe S, Tagami T, Ozeki T, Ichikawa T, Coelho PG, Jimbo R. The effect of simvastatin-loaded polymeric microspheres in a critical size bone defect in the rabbit calvaria. Int J Pharm. 2014;461(1–2):157–62. doi:10.1016/j.ijpharm.2013.11.046.

    Article  Google Scholar 

  47. Jeon JH, Puleo DA. Alternating release of different bioactive molecules from a complexation polymer system. Biomaterials. 2008;29(26):3591–8. doi:10.1016/j.biomaterials.2008.05.011.

    Article  Google Scholar 

  48. Ishtiaq S, Fogelman I, Hampson G. Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol Invest. 2015;38(1):13–29. doi:10.1007/s40618-014-0152-z.

    Article  Google Scholar 

  49. Alam S, Ueki K, Nakagawa K, Marukawa K, Hashiba Y, Yamamoto E, Sakulsak N, Iseki S. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):22–9.

    Article  Google Scholar 

  50. Takase H, Yano S, Yamaguchi T, Kanazawa I, Hayashi K, Yamamoto M, Yamauchi M, Sugimoto T. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells. Horm Metab Res. 2009;41(12):861–5.

    Article  Google Scholar 

  51. Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′, 5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Bone. 2009;44(5):872–7.

    Article  Google Scholar 

  52. Hisa I, Inoue Y, Hendy GN, Canaff L, Kitazawa R, Kitazawa S, Komori T, Sugimoto T, Seino S, Kaji H. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. J Biol Chem. 2011;286(11):9787–96.

    Article  Google Scholar 

Download references

Acknowledgments

This work was funded by a research grant to Zhejiang Provincial Health Department and Chinese Medicine Program (Grant Nos: 2016KYB196, 2016ZA140), Zhejiang Natural Science Foundation (Grant No: LY16H250002).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lei Yang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tao, ZS., Zhou, WS., Bai, Bl. et al. The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs. J Mater Sci: Mater Med 27, 43 (2016). https://doi.org/10.1007/s10856-015-5650-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10856-015-5650-9

Keywords

Navigation